Clinical trial diversity is a balancing act of time, quality, and money

While the topic of clinical trial diversity has been in circulation for some time, it has recently gained traction with the US Food and Drug Administration (FDA) releasing a guidance shepherding sponsors on the implementation of diversity plans.